Telemedicine and diabetes: achievements and prospects.

Simple item page
dc.contributor.authorFranc, S
dc.contributor.authorDaoudi, A
dc.contributor.authorMounier, S
dc.contributor.authorBoucherie, B
dc.contributor.authorDardari, D
dc.contributor.authorLaroye, H
dc.contributor.authorNeraud, B
dc.contributor.authorRequeda, E
dc.contributor.authorCanipel, L
dc.contributor.authorCharpentier, G
dc.date.accessioned2020-02-06T15:42:39Z
dc.date.available2020-02-06T15:42:39Z
dc.date.issued2011-12-13
dc.description.abstractHealth authorities currently have high expectations for telemedicine TM as it addresses several major challenges to improve access to healthcare especially for patients in underserved or remote areas to overcome the scarcity of specialists faced with epidemic disease and to reduce the costs of healthcare while improving quality The aims of TM in the field of diabetes differ according to the type of diabetes In type 1 diabetes T1DM associated with complex insulin regimens the goal of TM is to help patients achieve better control of their blood glucose levels through accurate adjustment of insulin doses In type 2 diabetes T2DM while therapeutic adjustments may be necessary improvement in blood glucose control is based primarily on behavioural changes reduced calorie and carbohydrate intakes increased physical activity Many TM studies focusing on management of blood glucose levels have been published but most failed to demonstrate any superiority of TM vs traditional care While previously published meta analyses have shown a slight advantage at best for TM these meta analyses included a mix of studies of varying durations and different populations both T1DM and T2DM patients adults and children and tested systems of inconsistent quality Studies published to date on TM suggest two currently promising approaches First handheld communicating devices such as smartphones loaded with software to apply physicians prescriptions have been shown to improve glycaemic control These systems provide immediate assistance to the patient such as insulin dose calculation and food choice optimization at meals and all data stored in the smartphone can be transmitted to authorized caregivers enabling remote monitoring and even teleconsultation These systems initially developed for T1DM appear to offer many possibilities for T2DM too Second systems combining an interactive Internet system or a mobile phone coupled to a remote server with a system of communication between the healthcare provider and the patient by e mail texting or phone calls have also shown certain benefits for glycaemic control These systems primarily aimed at T2DM patients generally provide motivational support as well Although the individual benefits of these systems for glycaemic control are fewer than with smartphones their widespread use should be of particular value for overcoming the relative shortage of doctors and reducing the health costs associated with a disease of such epidemic proportions
dc.identifier.urihttp://dx.doi.org/10.1016/j.diabet.2011.06.006
dc.identifier.urihttps://lib.digitalsquare.io/xmlui/handle/123456789/83
dc.relation.uriDiabetes And metabolism
dc.subjectFacility-based health worker
dc.subjectDemand for services
dc.subjectGeographic inaccessibility
dc.subjectLow adherence to treatments
dc.subjectDiabetes
dc.subjectChronic care
dc.subjectHealth education or promotion
dc.subjectTreatment adherence
dc.subjectRemote client-to-provider consultations (Telemedicine)
dc.subjectDisease management
dc.subjectData collection and reporting
dc.subjectSurveillance
dc.subjectInstalled application
dc.titleTelemedicine and diabetes: achievements and prospects.en
dcterms.abstractHealth authorities currently have high expectations for telemedicine TM as it addresses several major challenges to improve access to healthcare especially for patients in underserved or remote areas to overcome the scarcity of specialists faced with epidemic disease and to reduce the costs of healthcare while improving quality The aims of TM in the field of diabetes differ according to the type of diabetes In type 1 diabetes T1DM associated with complex insulin regimens the goal of TM is to help patients achieve better control of their blood glucose levels through accurate adjustment of insulin doses In type 2 diabetes T2DM while therapeutic adjustments may be necessary improvement in blood glucose control is based primarily on behavioural changes reduced calorie and carbohydrate intakes increased physical activity Many TM studies focusing on management of blood glucose levels have been published but most failed to demonstrate any superiority of TM vs traditional care While previously published meta analyses have shown a slight advantage at best for TM these meta analyses included a mix of studies of varying durations and different populations both T1DM and T2DM patients adults and children and tested systems of inconsistent quality Studies published to date on TM suggest two currently promising approaches First handheld communicating devices such as smartphones loaded with software to apply physicians prescriptions have been shown to improve glycaemic control These systems provide immediate assistance to the patient such as insulin dose calculation and food choice optimization at meals and all data stored in the smartphone can be transmitted to authorized caregivers enabling remote monitoring and even teleconsultation These systems initially developed for T1DM appear to offer many possibilities for T2DM too Second systems combining an interactive Internet system or a mobile phone coupled to a remote server with a system of communication between the healthcare provider and the patient by e mail texting or phone calls have also shown certain benefits for glycaemic control These systems primarily aimed at T2DM patients generally provide motivational support as well Although the individual benefits of these systems for glycaemic control are fewer than with smartphones their widespread use should be of particular value for overcoming the relative shortage of doctors and reducing the health costs associated with a disease of such epidemic proportions
dcterms.contributorFranc, S
dcterms.contributorDaoudi, A
dcterms.contributorMounier, S
dcterms.contributorBoucherie, B
dcterms.contributorDardari, D
dcterms.contributorLaroye, H
dcterms.contributorNeraud, B
dcterms.contributorRequeda, E
dcterms.contributorCanipel, L
dcterms.contributorCharpentier, G
dcterms.identifierhttp://dx.doi.org/10.1016/j.diabet.2011.06.006
dcterms.relationDiabetes And metabolism
dcterms.subjectFacility-based health worker
dcterms.subjectDemand for services
dcterms.subjectGeographic inaccessibility
dcterms.subjectLow adherence to treatments
dcterms.subjectDiabetes
dcterms.subjectChronic care
dcterms.subjectHealth education or promotion
dcterms.subjectTreatment adherence
dcterms.subjectRemote client-to-provider consultations (Telemedicine)
dcterms.subjectDisease management
dcterms.subjectData collection and reporting
dcterms.subjectSurveillance
dcterms.subjectInstalled application
dcterms.titleTelemedicine and diabetes: achievements and prospects.en
Files
Collections
mhealth Evidence